NovaBridge Biosciences Long-term Investment Intensity
NovaBridge Biosciences long-term investment intensity. NovaBridge Biosciences (NBP) has a Long-term Investment Intensity of 10.8% as of June 2026. Long-term investments of $25.06 Million represent 10.8% of total assets of $231.54 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Read NBP total debt and obligations for a breakdown of total debt and financial obligations.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Long-term Investment Intensity of NovaBridge Biosciences (2021–2025)
Long-term investment intensity of NovaBridge Biosciences from 2021 to 2025. This chart shows how NovaBridge Biosciences's Long-term Investment Intensity has evolved across 4 annual periods from 2021 to 2025. As of June 2026, the intensity stands at 10.8%, reflecting long-term investments of $25.06 Million against total assets of $231.54 Million USD.
NovaBridge Biosciences Long-term Investment Intensity by Year (2021–2025)
NovaBridge Biosciences long-term investment intensity by year from 2021 to 2025. The table below presents the year-by-year Long-term Investment Intensity for NovaBridge Biosciences from 2021 to 2025, covering 4 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see total assets of NovaBridge Biosciences.
| Year | LT Investment Intensity | LT Investments (USD) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2025 | 100.0% | $37.24 Million | $37.24 Million | ▲ +98.0 pp |
| 2024 | 2.0% | $30.82 Million | $1.55 Billion | ▲ +1.9 pp |
| 2022 | 0.1% | $4.47 Million | $4.07 Billion | ▼ -6.2 pp |
| 2021 | 6.3% | $55.24 Million | $878.74 Million | — |